Skip to main content
Plastic and Reconstructive Surgery Global Open logoLink to Plastic and Reconstructive Surgery Global Open
. 2022 Mar 7;10(3):e4164. doi: 10.1097/GOX.0000000000004164

Distal Internal Maxillary Artery Occlusion with Palatal Necrosis following Cheek Injection with Calcium Hydroxylapatite

Danny J Soares *,†,, Larry W Blevins *
PMCID: PMC8901201  PMID: 35265444

Summary:

Accidental intravascular injection of cosmetic fillers resulting in dermal infarction represents one of the most feared complications in aesthetic medicine. Despite the infrequency of these injuries, the rapid rise in filler use has caused a sudden increase in the incidence of filler-induced skin necrosis. Because the complex vascular anatomy of the face subserves a wide range of cutaneous and mucosal tissues, it has been surmised that occult injuries affecting the oronasal cavities could occur as a result of accidental intravascular injection of dermal fillers. We report an instance of ischemic skin injury of the infraorbital territory of the face with hemi-palatal mucosal necrosis secondary to vascular occlusion with calcium hydroxylapatite.


The rapid growth in the utilization of dermal fillers globally has led to a substantial increase in the number of reported cases of severe injuries resulting from accidental intravascular injection and embolization of filler.1 These injuries have the potential for devastating sequelae, ranging from disfiguring facial skin and soft tissue necrosis to vision loss, stroke, and death.2 Although occurrences of neuro-ophthalmological and dermal injuries have been well documented in the literature, those describing filler-induced mucosal infarcts have been seldom reported.3 These injuries, predominantly impacting the oral and nasal cavities, may be associated with additional muscular, dental, and bony damage that can be easily missed due to their occult nature.4 Here, we describe the first published instance of palatal necrosis arising from the inadvertent injection of dermal filler into the cheek.

CASE REPORT

A 64-year-old woman presented to the emergency department with sudden severe right facial pain, presyncope, and vomiting following cosmetic filler injections to the face approximately 4 hours earlier. The patient described having undergone an injection of calcium hydroxylapatite filler into the right medial cheek, by a board-certified plastic surgeon when she felt a severe sudden pain involving the right maxillary region. The treatment was paused, and the patient was allowed to recover, followed by subsequent resumption of the treatment. She was discharged home with instructions for routine use of cold compresses to the face. Within several hours, the patient began experiencing worsening of the cheek pain and new-onset palatal pain, nausea and vomiting, and visible discoloration of the right cheek and frontonasal region. Evaluation by the emergency room physician did not elucidate an underlying diagnosis, and the patient was managed with intravenous morphine, dexamethasone, and ketorolac and discharged home. The following day, the patient noticed worsening skin changes of the right cheek, as well as mucosal discoloration affecting the right hemi-palate (Fig. 1). She denied developing any nasal symptoms and noted no visual or neurological deficits. The patient was managed conservatively with wound dressings by her primary care physician, and she gradually recovered from the injury over several months. She did not return to her injecting practitioner for follow-up evaluation due to personal dissatisfaction with the treatment. She experienced severe maxillary pain for 6 weeks, and superficial necrosis of the right cheek and palatal mucosa, which gradually escharified and desquamated, as well as permanent ciliary madarosis of the upper eyelid. She presented to our clinic 15 months postinjury with persistent mild erythematous skin discoloration of the right cheek managed with three sequential 595-nm pulsed dye laser (Vbeam, Candela Corporation, Wayland, Mass.) monthly treatments with a favorable response and, ultimately, minimally-perceptible scarring. Her palatal mucosal injury healed without permanent sequelae.

Fig. 1.

Fig. 1.

Patient’s appearance 5 days post injection. A, Livedo reticularis of the right cheek and frontonasal region with central necrotic demarcation of the skin. B, Palatal ulceration following mucosal desquamation.

DISCUSSION

The potential ramifications of vascular occlusion within the arterial system of the face span a variety of complications, including tissue necrosis, blindness, and stroke. The risk of neuro-ophthalmological injury is substantially higher over regions supplied by the ophthalmic artery (such as the forehead, glabella, and nasal dorsum) because of its internal carotid artery origin. However, the possibility of substantial occult injury affecting the mucosal lining of the oronasal cavities arising predominantly from vaso-occlusive injuries of the external carotid arterial system have been predicted and included in a newly proposed FOEM (Facial, Ophthalmic, distal External carotid, and internal Maxillary arteries) scoring and grading system of facial necrosis (Fig. 2).5 The current case report describes the first published instance of hemi-palate necrosis arising from accidental intravascular injection of filler into the cheek. This injury, classified as F0O1E0M2 (Grade 3A), likely ensued following accidental cannulation of the infraorbital artery, a branch of the distal internal maxillary artery (IMax), resulting in retrograde arterial occlusion of the ipsilateral descending palatine artery.

Fig. 2.

Fig. 2.

The FOEM scoring system of facial skin necrosis. Each facial domain angiosome (facial, ophthalmic, distal external carotid, and internal maxillary) is subdivided into 10 distinct anatomical facial segments.

The IMax demonstrates substantial branching within the infratemporal fossa (Fig. 3), supplying the mucosa of the nonlingual oral surfaces and inferior nasal passages, as well as providing blood flow to the muscles of mastication and maxillary and mandibular bone and dentition. Despite its numerous branches and nurtured structures, the IMax artery has a limited cutaneous territory, which is supplied by its most terminal branch, the infraorbital artery. The infraorbital vascular territory coincides with the medial cheek fat compartment described by Rohrich and others, and injecting practitioners should recognize this skin region as being linked to the IMax angiosome.6,7 Due to its limited dermal territory, the IMax angiosome may be at a higher risk of occult necrosis that can be missed by the unsuspecting practitioner. As a result, individuals demonstrating signs of acute vascular occlusion should undergo a complete examination that includes a standard oral and nasal cavity inspection. In addition, due to the presence of true anastomoses between the infraorbital, facial, and dorsal nasal arteries, patients should also be screened for signs and symptoms of visual deficits and stroke through a standard neuro-ophthalmological evaluation and referred to the appropriate level of care, emergently if necessary. Preventive steps to help minimize the risk and extent of vascular injury with calcium hydroxylapatite have been published in several consensus guidelines and include favoring cannula use, limiting bolus size to less than 0.1 cm3, and injecting in a slow and retrograde fashion into safe planes of injection such as the preperiosteal plane for deep injections.8 In addition, avoiding calcium hydroxylapatite injection in high risk areas such as within the ophthalmic cutaneous angiosome, in surgerized tissues, and in areas with tenuous blood supply is advocated. Rapid identification, evaluation, and treatment are critical for minimization of severe sequelae such as skin necrosis and neuro-ophthalmological injury.9

Fig. 3.

Fig. 3.

The anatomy of the internal maxillary artery and its branches, redrawn with permission from Norton NS. Chapter 7: Temporal and infratemporal fossae. In Norton NS (Ed): Netter’s Head and Neck Anatomy for Dentistry. Philadelphia, PA: Elsevier; 2017:217.10

CONCLUSIONS

Acute vascular occlusion secondary to dermal filler injections can result in occult mucosal infarction of the oronasal cavities. In this case report, we describe a patient with undiagnosed palatal necrosis resulting from accidental intravascular injection of dermal filler into the right infraorbital artery. Practitioners must be mindful of the possibility of vascular occlusion in individuals demonstrating acute severe pain with tissue discoloration and be prepared to conduct a full examination that includes oral and nasal inspections to rule out mucosal necrosis, as well as a neuro-ophthalmological examination to identify any possible retinal or cerebrovascular injury.

PATIENT CONSENT

The patient provided written consent for the use of her image.

Footnotes

Published online 7 March 2022.

Disclosure: The authors have no financial interest to declare in relation to the content of this article.

REFERENCES

  • 1.FDA. Food and Drug Administration: Executive Summary General Issues Panel Meeting on Dermal Fillers. Available at https://www.fda.gov/media/146870/download. Published 2021. Accessed August 9, 2021.
  • 2.Beleznay K, Carruthers JD, Humphrey S, et al. Avoiding and treating blindness from fillers: a review of the world literature. Dermatol Surg. 2015;41:1097–1117. [DOI] [PubMed] [Google Scholar]
  • 3.Bravo BSF, Mariano Da Rocha CR, Bravo LG, et al. Septal ulcer after nasal filling with hyaluronic acid. J Clin Aesthet Dermatol. 2021;14:24–26. [PMC free article] [PubMed] [Google Scholar]
  • 4.Sharma S, Hackett R, Webb R, et al. Severe tissue necrosis following intra-arterial injection of endodontic calcium hydroxide: a case series. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:666–669. [DOI] [PubMed] [Google Scholar]
  • 5.Soares DJ, Bowhay A, Blevins LW, et al. Patterns of filler-induced facial skin necrosis: a systematic review of 243 cases and introduction of the F.O.E.M. scoring system and grading scale. Plast Reconstr Surg. 2022; In Press. [DOI] [PubMed] [Google Scholar]
  • 6.Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007;119:2219–2227. [DOI] [PubMed] [Google Scholar]
  • 7.Hufschmidt K, Bronsard N, Foissac R, et al. The infraorbital artery: clinical relevance in esthetic medicine and identification of danger zones of the midface. J Plast Reconstr Aesthet Surg. 2019;72:131–136. [DOI] [PubMed] [Google Scholar]
  • 8.van Loghem J, Funt D, Pavicic T, et al. Managing intravascular complications following treatment with calcium hydroxylapatite: an expert consensus. J Cosmet Dermatol. 2020;19:2845–2858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Humzah MD, Ataullah S, Chiang C, et al. The treatment of hyaluronic acid aesthetic interventional induced visual loss (AIIVL): a consensus on practical guidance. J Cosmet Dermatol. 2019;18:71–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Norton NS. Chapter 7: Temporal and infratemporal fossae. In Norton NS. (Ed): Netter’s Head and Neck Anatomy for Dentistry. Philadelphia, PA: Elsevier; 2017:217. [Google Scholar]

Articles from Plastic and Reconstructive Surgery Global Open are provided here courtesy of Wolters Kluwer Health

RESOURCES